Abstract
Following the definition of pain and a brief summary of the pain pathway, each level is analysed in more detail. The sensation of pain may originate from each level, and modulation takes place at each synaptic interface, with a multitude of chemical mediators involved. The importance of peripheral and central sensitization is stressed. Present knowledge and techniques of investigation of cerebral processing are discussed. Behavioural techniques of pain management are highlighted.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mersky H, Bogduk N. Classification of chronic pain. Seattle: IASP Press; 1994.
Iggo A. Cutaneous heat and cold receptors with slowly conducting ©afferent fibres. Quart J Exp Physiol. 1959;44:362–70.
Torebjörk HE, Schady W, Ochoa J. Sensory correlates of somatic afferent fibre activation. Hum Neurobiol. 1982;3(1):15–20.
Torebjörk HE, Ochoa J. New method to identify nociceptor units innervating glabrous skin of the human hand. Exp Brain Res. 1990;81(3):509–14.
Schaible HG, Grubb BD. Afferent and spinal mechanisms of joint pain. Pain. 1993;55:5–54.
Caterina MJ, Schumacher MA, Makoto T, Rosen TA, Levine DJ, Julius D. The capsaicin receptor: a heat activated ion channel in the pain pathway. Nature. 1997;389:816–24.
Derry S, Wiffen PJ, Kalso EA, Bell RF, Aldington D, Phillips T, Gaskell H, Moore RA. Topical analgesics for acute and chronic pain in adults‐an overview of cochrane reviews. Cochrane Database Syst Rev. 2017;5(3):CD008609.
Zhang JM, An J. Cytokines, inflammation and pain. Intl Anesthesiol Clin. 2007;45(2):27–37.
Iyengar S, Ossipov MH, Johnson KW. The role of calcitonin-related pain mechanisms including migraine. Pain. 2017;158(4):543–59.
Hirth M, et al. Nerve growth factor induces sensitization of nociceptors without evidence for increased intra-epidermal nerve fibre density. Pain. 2013;154:2500–11.
Yuan H, Lauritsen CG, Kaiser EA, Silberstein SD. CGRP monoclonal antibodies for migraine. BioDrugs. 2017;31(6):487–501.
Woolf CJ, Allchorne A, Safieh-Garabedian B, Poole S. Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumor necrosis factor. Br J Pharmacol. 1997;121:417–24.
Thacker M, Gifford L. Sympathetically maintained pain: myth or reality. 2013. https://giffordsachesandpains.files.wordpress.com/2013/06/04_chapteru.pdf.
Perl ED. Ideas about pain, a historical review. Nat Rev Neurosci. 2007;8:71–80.
Melzack R, Wall P. Pain mechanisms: a new theory. Science. 1965;150(3699):971–9.
Mendell LM. Constructing and deconstructing the gate theory of pain. Pain. 2014;155(2):210–6.
Christensen BN, Perl ER. Spinal neurones specifically excited by noxious or thermal stimuli: marginal zone of the dorsal horn. J Neurophysiol. 1970;33:293–307.
Brown AG, Hamann WC, Martin HF 3rd. Effects of activity in non-myelinated afferent fibres on the spinocervical tract. Brain Res. 1975;98(2):243–59.
Sindrup SH, Otto M, Finnerup NB, Jensen TS. Antidepressants in the treatment of neuropathic pain. Basic Clin Pharmacol Toxicol. 2005;96(6):399–409.
Rose MA, Kam PCA. Gabapentin: pharmacology and its use in pain management. Anaesthesia. 2002;57:451–62.
Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011;152:S2–S15.
Bannister K, Patel R, Goncalves L, Townson L, Dickenson AH. Diffuse noxious inhibitory controls and nerve injury: restoring an imbalance between descending monoamine inhibitions and facilitations. Pain. 2015;156(9):1803–11.
Hughes J, Smith TW, Kosterlitz HW, Fothergill LA, Morgan BA, Morris HR. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature. 1975;258:577–9.
Levine JD, Newton CG, Fields HL. The mechanism of placebo analgesia. Lancet. 1978;312:654–7.
Gruener H, Zeilig G, Laufer Y, Blumen N, Defrin R. Differential pain modulation properties in central neuropathic pain after spinal cord injury. Pain. 2016;157:1415–25.
Helyes Z, Tekus V, Szentes N, Pohoczky K, Botz B, et al. Non-inflammatory autoantibody-induced glia activation in a passive transfer complex regional pain syndrome. J Neurochemistry. 2017;142(Suppl. 1):255.
Woodhams SG, Chapman V, Finn DP, Hohmann AG, Neugebauer W. The cannabinoid system and pain. Neuropharmacology. 2017;124:105–20.
Abrams DI. The therapeutic effect of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report. Eur J Intern Med. 2018;49:7–11.
Wager TD, Atlas LY, Lindquist MA, Mathieu R, Choong WW. An fMRI-based neurologic signature of physical pain. N Engl J Med. 2013;368:1388–139.
Guenther K. “It’s all done with mirrors” V.S. Ramachandran and the material culture of phantom limb research. Med Hist. 2016;60:342–58.
Kumbhare DA. Evaluation of chronic pain using magnetic resonance (MR), neuroimaging approaches, what the clinician needs to know. Clin J Pain. 2017;33(4):281–90.
Pujol J, Martinez-Vilavella G, Llorente-Onaindia J, Harrison BJ, Lopez-Sola M, Lopez-Ruiz M, Bianco-Hinojo L, Benito P, Deus J, Monfort J. Brain imaging of pain sensitization in patients with in patients with knee osteoarthritis. Pain. 2017;158(9):1831–8.
Kabat-Zinn J. Mindfulness with Jon Kabat-Zinn. YouTube. 2007. https://www.youtube.com/watch?v=3nwwKbM_vJc.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Hamann, W. (2021). Pathophysiology of Pain. In: Shimoji, K., Nader, A., Hamann, W. (eds) Chronic Pain Management in General and Hospital Practice. Springer, Singapore. https://doi.org/10.1007/978-981-15-2933-7_4
Download citation
DOI: https://doi.org/10.1007/978-981-15-2933-7_4
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-2932-0
Online ISBN: 978-981-15-2933-7
eBook Packages: MedicineMedicine (R0)